1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions
申请人:Sabila Biosciences LLC
公开号:US10246444B2
公开(公告)日:2019-04-02
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.
本发明的组合物包括 1,2-二硫环戊烷、二硫醇及相关化合物,可作为治疗剂用于治疗和预防与表皮生长因子受体活性异常相关的疾病和病症。